Search filters

List of works by Kanamata Reddy

244-MPT overcomes gefitinib resistance in non-small cell lung cancer cells

scientific article published on 26 October 2015

3,6,2',4',5'-Pentahydroxyflavone, an orally bioavailable multiple protein kinase inhibitor, overcomes gefitinib resistance in non-small cell lung cancer

scientific article

A Small Molecule Inhibitor of the β-Catenin-TCF4 Interaction Suppresses Colorectal Cancer Growth In Vitro and In Vivo.

scientific article published on 27 September 2017

ADA-07 Suppresses Solar Ultraviolet-Induced Skin Carcinogenesis by Directly Inhibiting TOPK.

scientific article

APIO-EE-9 is a novel Aurora A and B antagonist that suppresses esophageal cancer growth in a PDX mouse model

scientific article published on 16 June 2017

Aurora B kinase as a novel molecular target for inhibition the growth of osteosarcoma

scientific article published on 01 March 2019

CInQ-03, a novel allosteric MEK inhibitor, suppresses cancer growth in vitro and in vivo

scientific article published on 25 January 2013

Discovery of the novel mTOR inhibitor and its antitumor activities in vitro and in vivo

scientific article published on 27 March 2013

HI-511 overcomes melanoma drug resistance via targeting AURKB and BRAF V600E

scientific article published on 01 August 2020

Identification of an Aurora kinase inhibitor specific for the Aurora B isoform.

scientific article

Identification of mammalian target of rapamycin as a direct target of fenretinide both in vitro and in vivo

scientific article

Norathyriol Suppresses Skin Cancers Induced by Solar Ultraviolet Radiation by Targeting ERK Kinases

scientific article

Novel TOPK inhibitor HI-TOPK-032 effectively suppresses colon cancer growth.

scientific article

PPMP, a novel tubulin-depolymerizing agent against esophageal cancer in patient-derived tumor xenografts

scientific article published on 27 April 2016

TRPV1-antagonist AMG9810 promotes mouse skin tumorigenesis through EGFR/Akt signaling

scientific article published on February 23, 2011

The Ashitaba (Angelica keiskei) Chalcones 4-hydroxyderricin and Xanthoangelol Suppress Melanomagenesis By Targeting BRAF and PI3K

scientific article published on 06 July 2018

The P110 subunit of PI3-K is a therapeutic target of acacetin in skin cancer

scientific article published on 02 August 2013

USP8 is a novel target for overcoming gefitinib resistance in lung cancer

scientific article published on 07 June 2013